<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220203053927N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-02-10</date_registration>
      <primary_sponsor>Shahroud University of Medical Sciences</primary_sponsor>
      <public_title>The effect of prenatal supportive care of midwives in pregnant women with chronic diseases</public_title>
      <acronym></acronym>
      <scientific_title>The effect of prenatal supportive care of midwives in pregnant women with chronic diseases: Randomized Controlled Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-02-26</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>204</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/61761</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Eligible women will randomly assign into two groups of routine (individual) prenatal care or group prenatal care using block randomization with a block size of 4 and an allocation ratio of 1:1. Thus, after listing all possible situations of 4 blocks and assigning a number to each of them using a computer random number table with a 1: 1 ratio, participants will be allocated into two groups, namely routine prenatal care and supportive care care. For allocation concealment, each woman will receive a code and all codes will be kept in an opaque envelope until the time of intervention. Sequencing of allocation and preparation of envelopes will be done by a person that will not involve sampling and data collection. The researcher and the participant will not aware of the groups and the intervention that they received until the commencement of intervention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>prenatal supportive care.</hc_freetext>
      <i_freetext>Intervention 1: InterIntervention group: Supportive prenatal care in the intervention group consists of 3 components: (1) active and passive telephone counseling before and after delivery, (2) coordination of care and case management, (3) continuous care buyDedicated midwife during pregnancy, during labor and delivery.Individuals in the prenatal care intervention group will receive the researcher in the specialized clinic of the selected hospital in weeks 30-24, 34-31, 37-35, 38, 39, 40.The researcher works in consultation with a perinatologist.At each visit, while examining the individual needs and desires of each woman, counseling and training appropriate to the gestational age will be provided individually and face to face.During the intervention period, the researcher will have one phone call per week with the participants and in each post-greeting call, she will examine three main areas: physical-mental health status and pregnancy health, evaluation-based recommendations, and discussion about Any other additional issues that are important to the mother.In this intervention, each participant can contact the midwife whenever they need to be consulted.Care coordination will be done by the researcher during the intervention period.The researcher identifies the specific needs and wants of each woman and discusses the optimal care of the woman with the obstetrician who is responsible for her medical care.The intervention group will be supported by the researcher as a companion midwife (Dola) from the beginning of the mother's hospitalization (beginning of the active phase of labor in the expansion of the cervix 3-4 cm) until the first 2 hours after delivery.The researcher will provide supportive measures for the mother during labor, classified into psychological, emotional, educational, and physical categories.The researcher will also be able to follow up and respond to maternal problems by phone and, if necessary, in person after the first 2 hours of labor. Intervention 2: Control group: The control group will receive routine care at the prenatal care clinic of the selected hospital by the resident on duty and under the supervision of a perinatologist. Routine pregnancy care  based on national protocol includes 8 visits (in weeks 6-10, 20-16, 30-24, 34-31, 37-35, 38, 39, 40) which Based on the severity of the chronic disease and the risks associated with pregnancy, the treating physician will set up an individual care plan for each person's visit and care.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The data can be published after the completion of the dissertation

When:
One year after completing the dissertation

To whom:
Shahroud and Ahvaz University of Medical Sciences, Hospital Officials, Researchers

Conditions:
Data analysis through publication in scientific research journals in
They will be available to others

Where to obtain:
solmaz mohammadi, E mail: sl.mohammadi89@yahoo.com

How to obtain:
The information will be available through the publication
of the article. But if more information is needed, the
request should be sent via email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Motaghi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Haftam Tir Square - Shahroud University of Medical Sciences and Health Services</address>
        <city>Shahroud</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۳۶۱۴۷-۷۳۹۴۳</zip>
        <telephone>+98 23 3239 5009</telephone>
        <email>Zahra.motagy63@gmail.com</email>
        <affiliation>Shahroud University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Solmaz Mohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Golestan Alley, Dey Bin Bahman and Esfand St.No.116</address>
        <city>Ahvaz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6135935697</zip>
        <telephone>+98 61 3321 9122</telephone>
        <email>sl.mohammadi89@yahoo.com</email>
        <affiliation>Shahroud University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1.Pregnant women with one or more chronic diseases that are diagnosed more than 6 months before pregnancy, with continued recurrence and need for medical treatment
2.Be between 16-20 weeks pregnant at the time of enrollment in the study
3.Single pregnancy
4.Be able to understand Persian speech and writing
5.To live in Ahvaz
6.Having a cell phone
7.Satisfaction to participate in the study</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>1.Self-report history of substance abuse
2.Self-report of mental disorder and use of psychiatric drugs
3.Reluctance to continue participating in the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>O36.7</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Maternal care for viable fetus in abdominal pregnancy</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>N/A</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>InterIntervention group: Supportive prenatal care in the intervention group consists of 3 components: (1) active and passive telephone counseling before and after delivery, (2) coordination of care and case management, (3) continuous care buyDedicated midwife during pregnancy, during labor and delivery.Individuals in the prenatal care intervention group will receive the researcher in the specialized clinic of the selected hospital in weeks 30-24, 34-31, 37-35, 38, 39, 40.The researcher works in consultation with a perinatologist.At each visit, while examining the individual needs and desires of each woman, counseling and training appropriate to the gestational age will be provided individually and face to face.During the intervention period, the researcher will have one phone call per week with the participants and in each post-greeting call, she will examine three main areas: physical-mental health status and pregnancy health, evaluation-based recommendations, and discussion about Any other additional issues that are important to the mother.In this intervention, each participant can contact the midwife whenever they need to be consulted.Care coordination will be done by the researcher during the intervention period.The researcher identifies the specific needs and wants of each woman and discusses the optimal care of the woman with the obstetrician who is responsible for her medical care.The intervention group will be supported by the researcher as a companion midwife (Dola) from the beginning of the mother's hospitalization (beginning of the active phase of labor in the expansion of the cervix 3-4 cm) until the first 2 hours after delivery.The researcher will provide supportive measures for the mother during labor, classified into psychological, emotional, educational, and physical categories.The researcher will also be able to follow up and respond to maternal problems by phone and, if necessary, in person after the first 2 hours of labor.</i_keyword>
      <i_keyword>Control group: The control group will receive routine care at the prenatal care clinic of the selected hospital by the resident on duty and under the supervision of a perinatologist. Routine pregnancy care  based on national protocol includes 8 visits (in weeks 6-10, 20-16, 30-24, 34-31, 37-35, 38, 39, 40) which Based on the severity of the chronic disease and the risks associated with pregnancy, the treating physician will set up an individual care plan for each person's visit and care.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The length of hospital stay (mean and standard deviation) is measured from the time of admission to the study until 2 weeks after delivery. Timepoint: Evaluation of this outcome will be done 2 weeks after delivery. Method of measurement: medical records.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>World Health Organization 5-item Welfare Index. Timepoint: The evaluation will be performed at the beginning of the study (baseline), at 33-37 weeks of gestation and 6 weeks after delivery. Method of measurement: World Health Organization 5-item Welfare Scale World Health Organization 5-item Welfare Scale Questionnaire.</sec_outcome>
      <sec_outcome>Pregnancy and postpartum depression. Timepoint: The evaluation will be performed at the beginning of the study (baseline), at 33-37 weeks of gestation and 6 weeks after delivery. Method of measurement: Edinburgh Postpartum Depression Scale.</sec_outcome>
      <sec_outcome>Pregnancy worries. Timepoint: The evaluation will be done at the beginning of the study (baseline) and at 33-37 weeks of pregnancy. Method of measurement: Cambridge Pregnancy Anxiety Scale Questionnaire.</sec_outcome>
      <sec_outcome>Health-related quality of life. Timepoint: The evaluation will be performed at the beginning of the study (baseline), at 33-37 weeks of gestation and 6 weeks after delivery. Method of measurement: Health-related quality of life questionnaire.</sec_outcome>
      <sec_outcome>Quality  prenatal care from the perspective of service recipients. Timepoint: Evaluation 6 weeks after delivery. Method of measurement: Quality of Prenatal Care Questionnaire.</sec_outcome>
      <sec_outcome>Satisfaction with childbirth. Timepoint: Evaluation 2 weeks after delivery. Method of measurement: Maki Maternity Satisfaction Scale.</sec_outcome>
      <sec_outcome>Economic consequences of health (use of health services). Timepoint: Evaluation 6 weeks after delivery. Method of measurement: Researcher-made questionnaire.</sec_outcome>
      <sec_outcome>Prenatal health behaviors. Timepoint: The evaluation will be done at the beginning of the study (baseline) and at 33-37 weeks of pregnancy. Method of measurement: Prenatal health behaviors scale.</sec_outcome>
      <sec_outcome>Consequences of pregnancy and childbirth. Timepoint: Evaluation 6 weeks after delivery. Method of measurement: Researcher-made questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahroud University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-12-01</approval_date>
        <contact_name>Shahroud University of Medical Sciences</contact_name>
        <contact_address>Shahroud ,7th of Tir Square - Shahroud University of Medical Sciences and Health Services Shahroud Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
